|18th March 2020||Gail S Page||8,810||Payment by withholding||$2.36||$20,791.60|
|17th January 2020||Gail S Page||30,864||Grant/award etc.||$0.00|
|11th November 2019||John Gary Potthoff||10,000||Open or private purchase||$4.44||$44,400.00|
|18th June 2019||John J Iii Sperzel||375,000||Grant/award etc.||$0.00|
|24th May 2019||Javan Esfandiari||9,744||Open or private sale||$6.95||$67,726.65|
|23rd May 2019||Javan Esfandiari||12,956||Open or private sale||$7.15||$92,582.28|
|22nd May 2019||Javan Esfandiari||7,300||Open or private sale||$7.41||$54,125.12|
|6th May 2019||Katherine Lyon Davis||46,875||Exercise of derivative||$3.48||$163,125.00|
|6th May 2019||Katherine Lyon Davis||22,800||Payment by withholding||$7.15||$163,122.60|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.
Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The company was founded in 1985 and is headquartered in Medford, NY.